Loading…
Lightchain Capital is a venture capital fund that invests in early-stage life sciences companies focused on improving cancer patient outcomes. The fund supports innovative therapies, such as C4 Therapeutics' CFT1946, a targeted treatment for BRAF V600 mutant solid tumors.
We haven’t found Lightchain Capital in the AI answers we’ve checked.
